10 completed, 1 terminated, 1 unknown. 12 Phase 3.
By phase and status
Follow Helping Behavior: new trials by email Literature Review of Helping Behavior trials Research Report on Helping Behavior
Trials (filtered) newest first · largest first
All 12 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)
Pergoveris®, GONAL-f®, Recombinant human chorionic gonadotrophin (r-hCG) - Infertility | Phase 3 | Completed | 939 | 2014-01-31 | 2017-08-24 |
"Effectiveness of a Brief Intervention for Substances Consumption Linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): A Randomized Control Trial in Chilean Primary Care."
ASSIST-linked brief intervention for hazardous and harmful substance use., Observation - Alcohol-Related Disorders, Substance-Related Disorders | Phase 3 | Completed | 400 | 2011-12-01 | 2013-10-09 |
PERgoveriS In Stratified Treatment for Assisted Reproductive Technique
Gonal-f®, Pergoveris®, Recombinant human chorionic gonadotropin (r-hCG) - Assisted Reproductive Techniques, Reproductive Technology, Assisted | Phase 3 | Completed | 202 | 2011-05-31 | 2021-05-28 |
Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031)
Corifollitropin alfa, recFSH (follitropin beta) - Infertility | Phase 3 | Completed | 307 | 2010-06-02 | 2024-06-20 |
Efficacy and Safety Study of a Single Injection of SCH 900962 Versus Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (Study P06029)
SCH 900962 / Corifollitropin alfa / Org 36286, RecFSH / follitropin beta, Placebo for SCH 900962 - Infertility | Phase 3 | Completed | 1424 | 2010-06-01 | 2022-02-03 |
Safety and Efficacy of Lidocaine Infiltration in Suction Assisted Lipectomy
Lidocaine - Healthy | Phase 3 | Unknown | 60 | 2007-12-01 | 2008-01-11 |
A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)
ganirelix, triptorelin - Controlled Ovarian Stimulation | Phase 3 | Completed | 259 | 2007-05-01 | 2022-02-03 |
SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women
Gonalef® (Follitropin alfa), Purified pituitary gonadotropin (Fertinorm-P®) - Infertility, Ovulation Induction | Phase 3 | Completed | 300 | 2007-02-01 | 2013-12-27 |
Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle
Recombinant human Follicle Stimulating Hormone (r-hFSH) and Recombinant human Luteinizing Hormone (r-hLH), r-hFSH - Reproductive Techniques, Assisted | Phase 3 | Terminated | 133 | 2005-03-01 | 2013-12-27 |
A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive Technologies
Recombinant Human-Luteinizing Hormone (Luveris) - Infertility, Ovarian Stimulation | Phase 3 | Completed | 55 | 2004-09-01 | 2013-08-07 |
A Study Using Micronised Progesterone (Crinone® 8%) in the Luteal Phase Support of Women Undergoing in Vitro Fertilisation (IVF) and Embryo Transfer (ET)
Micronised Progesterone, Progesterone - Infertility | Phase 3 | Completed | 238 | 2004-05-01 | 2014-07-31 |
A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET)
r-hCG, Urinary-hCG - Infertility | Phase 3 | Completed | 218 | 2003-12-01 | 2014-07-31 |
Narrower conditions
Infertility (7) · Alcohol-Related Disorders (1) · Polycystic Ovary Syndrome (1) · Substance-Related Disorders (1)
Broader conditions
Behavior (12) · Social Behavior (12) · Genital Diseases (7) · Urogenital Diseases (7) · Adnexal Diseases (1) · Chemically-Induced Disorders (1) · Cysts (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases, Female (1) · Gonadal Disorders (1) · Mental Disorders (1) · Neoplasms (1) · Ovarian Cysts (1)
Interventions
Chorionic Gonadotropin (3) · Ovidrel (3) · follitropin alfa (3) · follicle stimulating hormone, human, with HCG C-terminal peptide (2) · follitropin beta (2) · pergoveris (2) · Lidocaine (1) · Luteinizing Hormone, beta Subunit (1) · Observation (1) · Profasi (1) · Progesterone (1) · Triptorelin Pamoate (1) · Urofollitropin (1) · ganirelix (1)
Sponsors
Merck KGaA, Darmstadt, Germany (6) · Organon and Co (3) · EMD Serono (1) · Hospital Militar de Santiago (1) · Pontificia Universidad Catolica de Chile (1)
Countries
Chile (2) · China (2) · Germany (2) · Italy (2) · Denmark (1) · Finland (1) · France (1) · Greece (1) · Japan (1) · Netherlands (1) · Poland (1) · Russia (1) · Slovakia (1) · United Kingdom (1)
Top investigators
Huafei Li (2) · Fernando Poblete, MD, MPH (1) · Guillermo Israel, MD (1) · Kimitoshi Takemura (1) · Montserrat Fontbona, MD (1) · Rodrigo Cabello, MD (1) · Salvatore Longobardi (1) · Salvatore Longobardi, MD (1) · Stefan Danilla, MD, MSc (1)
Results publications
PMID 22429192, PMID 23897332, PMID 26003273, PMID 26141305, PMID 26194884, PMID 26520396, PMID 26991902, PMID 27090863, PMID 27619773, PMID 28137754, PMID 29699333, PMID 37158538
NIH funding
2004 (1)